195 related articles for article (PubMed ID: 26396095)
21. A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis.
Floreani A; Zappala F; Fries W; Naccarato R; Plebani M; D'Angelo A; Chiaramonte M
J Clin Gastroenterol; 1997 Jun; 24(4):239-44. PubMed ID: 9252849
[TBL] [Abstract][Full Text] [Related]
22. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
23. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
Tałałaj M; Gradowska L; Marcinowska-Suchowierska E; Durlik M; Gaciong Z; Lao M
Transplant Proc; 1996 Dec; 28(6):3485-7. PubMed ID: 8962355
[No Abstract] [Full Text] [Related]
24. Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate.
Khajehdehi P; Taheri S
J Ren Nutr; 2003 Apr; 13(2):78-83. PubMed ID: 12671829
[TBL] [Abstract][Full Text] [Related]
25. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallel-group, controlled, prospective study.
Ciria-Recasens M; Blanch-Rubió J; Coll-Batet M; Del Pilar Lisbona-Pérez M; Díez-Perez A; Carbonell-Abelló J; Manasanch J; Pérez-Edo L
Clin Drug Investig; 2011 Dec; 31(12):817-24. PubMed ID: 22035462
[TBL] [Abstract][Full Text] [Related]
27. Relationship between increased endogenous parathormone levels and bone density in postmenopausal women treated with bisphosphonates.
Coin A; Veronese N; Bolzetta F; De Rui M; Manzato E; Sergi G
Panminerva Med; 2012 Dec; 54(4):277-82. PubMed ID: 23123579
[TBL] [Abstract][Full Text] [Related]
28. Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.
Rhee Y; Kang M; Min Y; Byun D; Chung Y; Ahn C; Baek K; Mok J; Kim D; Kim D; Kim H; Kim Y; Myoung S; Kim D; Lim SK
Osteoporos Int; 2006 Dec; 17(12):1801-7. PubMed ID: 17019520
[TBL] [Abstract][Full Text] [Related]
29. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG).
Sasaki N; Kusano E; Takahashi H; Ando Y; Yano K; Tsuda E; Asano Y
J Bone Miner Metab; 2005; 23(1):41-7. PubMed ID: 15616893
[TBL] [Abstract][Full Text] [Related]
30. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
31. Alendronate prevents further bone loss in renal transplant recipients.
Giannini S; D'Angelo A; Carraro G; Nobile M; Rigotti P; Bonfante L; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
J Bone Miner Res; 2001 Nov; 16(11):2111-7. PubMed ID: 11697808
[TBL] [Abstract][Full Text] [Related]
32. Bone mineral density and vitamin D status in children with remission phase of steroid-sensitive nephrotic syndrome.
Cetin N; Gencler A; Sivrikoz IA
Saudi J Kidney Dis Transpl; 2019; 30(4):853-862. PubMed ID: 31464242
[TBL] [Abstract][Full Text] [Related]
33. Low bone mineral density and vitamin d deficiency correlated with genetics and other bone markers in female Turkish immigrants in Germany.
Tastan Y; Kann PH; Tinneberg HR; Hadji P; Müller-Ladner U; Lange U
Clin Rheumatol; 2016 Nov; 35(11):2789-2795. PubMed ID: 27034172
[TBL] [Abstract][Full Text] [Related]
34. Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis.
Nuti R; Bianchi G; Brandi ML; Caudarella R; D'Erasmo E; Fiore C; Isaia GC; Luisetto G; Muratore M; Oriente P; Ortolani S
Rheumatol Int; 2006 Mar; 26(5):445-53. PubMed ID: 16283320
[TBL] [Abstract][Full Text] [Related]
35. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[TBL] [Abstract][Full Text] [Related]
36. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
Pańczyk-Tomaszewska M; Adamczuk D; Kisiel A; Skrzypczyk P; Przedlacki J; Górska E; Stelmaszczyk-Emmel A; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 840():21-8. PubMed ID: 25310960
[TBL] [Abstract][Full Text] [Related]
37. Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome.
Koşan C; Ayar G; Orbak Z
West Indian Med J; 2012 Sep; 61(6):627-30. PubMed ID: 23441359
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
39. Control of parathyroid function in patients with a short history of hemodialysis.
Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
[TBL] [Abstract][Full Text] [Related]
40. The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low bone mass.
Xia WB; Zhang ZL; Wang HF; Meng XW; Zhang Y; Zhu GY; Xing XP; Liu JL; Wang LH; Jiang Y; Weng SF; Xu T; Hu YY; Yu W; Tian JP
Acta Pharmacol Sin; 2009 Mar; 30(3):372-8. PubMed ID: 19262561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
